Research ND

• Commercialization of new technologies
• Research and development of new products
• Improvement of existing products or processes

1. Research ND BIO for the development and commercialization of vaccines and antibodies for the prevention of, treatment of, or cure for cancer; virally infectious disease; or other pathogens, including bacteria, mycobacteria, fungi and parasites.
2. Fast Track was designed to allow companies dealing with unforeseen circumstances or time-sensitive projects to utilize the expertise at North Dakota research universities.  Fast Track funds may be used for projects that have:
   • An expected project duration of less than 1 year;
   • A compelling reason to start immediately; and
   • A private sector partner with a substantial presence in North Dakota or active collaboration with a North Dakota manufacturer.

Venture Grants

• Phase I Venture Grants are intended to determine the feasibility of building a business around university technology. Acceptable uses of Venture Grant funds include:
  • Analysis of the potential market
  • Assessment of the technologies’ readiness
  • Further advancement of technology
  • Intellectual property costs

• Phase II Venture Grant applications will only be accepted from individuals/groups that have successfully completed a Phase I award. Phase II provides matching funds to the research university to continue refining the technology for market. The research university’s identified private sector partner may be:
  • An early stage company; or
  • An individual interested in starting a business using university technology.

Venture Grant - Due to the limited funds available, no Phase I grants will be awarded in the 2017-19 Biennium.



 

To access information related to program policies and applications, please visit Research ND Resources.